Esters of quinoxaline-7-carboxylate-1,4-di-N-oxide as Trichomonas vaginalis triosephosphate isomerase inhibitors
Trichomoniasis is a public health problem worldwide. Trichomoniasis treatment consists of the use of nitroimidazole derivatives; however, therapeutic ineffectiveness occurs in 5 to 20 % of the cases. Therefore, it is essential to propose new pharmacological agents against this disease. In this work,...
Saved in:
Main Authors: | Palos Isidro, Moo-Puc Rosa, Vique-Sánchez José Luis, Benítez-Cardoza Claudia G., Monge Antonio, Villalobos-Rocha Juan Carlos, Paz-Gonzalez Alma D., Rivera Gildardo |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2021-09-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2021-0032 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chemistry and pharmacological diversity of quinoxaline motifs as anticancer agents
by: Ajani Olayinka O., et al.
Published: (2019-06-01) -
An insight into the therapeutic impact of quinoxaline derivatives: Recent advances in biological activities (2020–2024)
by: Aly M. Waseem, et al.
Published: (2025-01-01) -
The Laboratory Diagnosis of Trichomonas vaginalis
by: Gary E Garber
Published: (2005-01-01) -
New Concepts in the Diagnosis and Pathogenesis of Trichomonas vaginalis
by: Renuka Bhatt, et al.
Published: (1996-01-01) -
Correlation between Trichomonas vaginalis and Concurrency: An Ecological Study
by: Chris R. Kenyon, et al.
Published: (2016-01-01)